These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 19517018)
1. Aging is not associated with proteasome impairment in UPS reporter mice. Cook C; Gass J; Dunmore J; Tong J; Taylor J; Eriksen J; McGowan E; Lewis J; Johnston J; Petrucelli L PLoS One; 2009 Jun; 4(6):e5888. PubMed ID: 19517018 [TBL] [Abstract][Full Text] [Related]
2. The neuronal ubiquitin-proteasome system: murine models and their neurological phenotype. van Tijn P; Hol EM; van Leeuwen FW; Fischer DF Prog Neurobiol; 2008 Jun; 85(2):176-93. PubMed ID: 18448229 [TBL] [Abstract][Full Text] [Related]
3. Spatiotemporal progression of ubiquitin-proteasome system inhibition after status epilepticus suggests protective adaptation against hippocampal injury. Engel T; Martinez-Villarreal J; Henke C; Jimenez-Mateos EM; Sanz-Rodriguez A; Alves M; Hernandez-Santana Y; Brennan GP; Kenny A; Campbell A; Lucas JJ; Henshall DC Mol Neurodegener; 2017 Feb; 12(1):21. PubMed ID: 28235423 [TBL] [Abstract][Full Text] [Related]
4. Acute polyglutamine expression in inducible mouse model unravels ubiquitin/proteasome system impairment and permanent recovery attributable to aggregate formation. Ortega Z; Díaz-Hernández M; Maynard CJ; Hernández F; Dantuma NP; Lucas JJ J Neurosci; 2010 Mar; 30(10):3675-88. PubMed ID: 20220001 [TBL] [Abstract][Full Text] [Related]
5. Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment. Maynard CJ; Böttcher C; Ortega Z; Smith R; Florea BI; Díaz-Hernández M; Brundin P; Overkleeft HS; Li JY; Lucas JJ; Dantuma NP Proc Natl Acad Sci U S A; 2009 Aug; 106(33):13986-91. PubMed ID: 19666572 [TBL] [Abstract][Full Text] [Related]
6. A novel transgenic mouse model reveals deregulation of the ubiquitin-proteasome system in the heart by doxorubicin. Kumarapeli AR; Horak KM; Glasford JW; Li J; Chen Q; Liu J; Zheng H; Wang X FASEB J; 2005 Dec; 19(14):2051-3. PubMed ID: 16188962 [TBL] [Abstract][Full Text] [Related]
7. Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease. van Tijn P; de Vrij FM; Schuurman KG; Dantuma NP; Fischer DF; van Leeuwen FW; Hol EM J Cell Sci; 2007 May; 120(Pt 9):1615-23. PubMed ID: 17405812 [TBL] [Abstract][Full Text] [Related]
8. Long-term proteasomal inhibition in transgenic mice by UBB(+1) expression results in dysfunction of central respiration control reminiscent of brainstem neuropathology in Alzheimer patients. Irmler M; Gentier RJ; Dennissen FJ; Schulz H; Bolle I; Hölter SM; Kallnik M; Cheng JJ; Klingenspor M; Rozman J; Ehrhardt N; Hermes DJ; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Meyer HE; Hopkins DA; Van Leeuwen FW; Beckers J Acta Neuropathol; 2012 Aug; 124(2):187-97. PubMed ID: 22730000 [TBL] [Abstract][Full Text] [Related]
9. Testing the ubiquitin-proteasome hypothesis of neurodegeneration in vivo. Hernández F; Díaz-Hernández M; Avila J; Lucas JJ Trends Neurosci; 2004 Feb; 27(2):66-9. PubMed ID: 15106649 [TBL] [Abstract][Full Text] [Related]
11. Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons. Tydlacka S; Wang CE; Wang X; Li S; Li XJ J Neurosci; 2008 Dec; 28(49):13285-95. PubMed ID: 19052220 [TBL] [Abstract][Full Text] [Related]
12. Low levels of mutant ubiquitin are degraded by the proteasome in vivo. van Tijn P; Verhage MC; Hobo B; van Leeuwen FW; Fischer DF J Neurosci Res; 2010 Aug; 88(11):2325-37. PubMed ID: 20336771 [TBL] [Abstract][Full Text] [Related]
13. Fluorescent Tools for In Vivo Studies on the Ubiquitin-Proteasome System. Matilainen O; Jha S; Holmberg CI Methods Mol Biol; 2016; 1449():215-22. PubMed ID: 27613038 [TBL] [Abstract][Full Text] [Related]
14. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Bowman AB; Yoo SY; Dantuma NP; Zoghbi HY Hum Mol Genet; 2005 Mar; 14(5):679-91. PubMed ID: 15661755 [TBL] [Abstract][Full Text] [Related]
15. A photoconvertible reporter of the ubiquitin-proteasome system in vivo. Hamer G; Matilainen O; Holmberg CI Nat Methods; 2010 Jun; 7(6):473-8. PubMed ID: 20453865 [TBL] [Abstract][Full Text] [Related]
16. Complement modulates the function of the ubiquitin-proteasome system and endoplasmic reticulum-associated degradation in glomerular epithelial cells. Kitzler TM; Papillon J; Guillemette J; Wing SS; Cybulsky AV Biochim Biophys Acta; 2012 May; 1823(5):1007-16. PubMed ID: 22426620 [TBL] [Abstract][Full Text] [Related]
17. A transgenic mouse model of the ubiquitin/proteasome system. Lindsten K; Menéndez-Benito V; Masucci MG; Dantuma NP Nat Biotechnol; 2003 Aug; 21(8):897-902. PubMed ID: 12872133 [TBL] [Abstract][Full Text] [Related]
18. The regulation of proteostasis in glial cells by nucleotide receptors is key in acute neuroinflammation. de Diego García L; Sebastián-Serrano Á; Hernández IH; Pintor J; Lucas JJ; Díaz-Hernández M FASEB J; 2018 Jun; 32(6):3020-3032. PubMed ID: 29401585 [TBL] [Abstract][Full Text] [Related]